Skip to main content
SpringerLink
Log in

Questions and Answers

  • Published:
Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dever D, Tarasi A, Tomasz A. Bactericidal activity of RP59500 (RP) against Streptococcus pneumoniae in the rabbit model of experimental meningitis. 3rd International Conference on the Macrolides, Azalides and Streptogramins (ICMAS). 24–27 Jan 1996, Lisbon, Portugal

  2. Freeman C, Robinson A, Cooper B, et al. In vitro antimicrobial susceptibility of glycopeptide-resistant enterococci. Diagn Microbiol Infect Dis 1995; 21: 47–50.

    Article  PubMed  Google Scholar 

  3. Cercenado E, Diaz MD, Sanchez-Carrillo C, et al. Enhanced activity of the combination of penicillin G and gentamicin against penicillin-resistant viridans group streptococci. Antimicrob Agents Chemother 1995; 39: 2816–8.

    Article  PubMed  CAS  Google Scholar 

  4. Bastin R, J Frottier, JC Pechère, et al. Résultats thérapeutiques des associations d’antibiotiques bactéricides dans les infections septicémiques. Pathol Biol 1971; 19: 585–91.

    PubMed  CAS  Google Scholar 

  5. Baltch AL, Smith RP, Ritz W. In vitro effect of RP59500 (quinupristin/dalfopristin) and ampicillin (Amp) on vancomycin-resistant enterococci (VRE), singly and in combination [abstract no. 152]. 95th General Meeting of the American Society for Microbiology. 21–25 May 1995, Washington DC

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Questions and Answers. Drugs 51 (Suppl 1), 43–45 (1996). https://doi.org/10.2165/00003495-199600511-00009

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003495-199600511-00009

Keywords

Search

Navigation